NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia.
about
Memantine for schizophreniaThe dysconnection hypothesis (2016)In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric DisordersAuditory dysfunction in schizophrenia: integrating clinical and basic features.Stress and neurodevelopmental processes in the emergence of psychosisTranslating the MAM model of psychosis to humansContributions of cortical feedback to sensory processing in primary visual cortexCollagen-derived matricryptins promote inhibitory nerve terminal formation in the developing neocortex.Inhibition of parvalbumin-expressing interneurons results in complex behavioral changes.Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801Schizophrenia: One Coat of Many ColorsFrom Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids MetabolismEmotional and cognitive dysregulation in schizophrenia and depression: understanding common and distinct behavioral and neural mechanismsHow Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of PsychosisSpatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia.Synaptic interactions and inhibitory regulation in auditory cortexImpaired prefrontal synaptic gain in people with psychosis and their relatives during the mismatch negativity.Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.Behavioral effects of the benzodiazepine-positive allosteric modulator SH-053-2'F-S-CH₃ in an immune-mediated neurodevelopmental disruption model.Optogenetic activation of an inhibitory network enhances feedforward functional connectivity in auditory cortex.Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders.Knockout of NMDA receptors in parvalbumin interneurons recreates autism-like phenotypes.Crybb2 coding for βB2-crystallin affects sensorimotor gating and hippocampal function.Augmented gamma band auditory steady-state responses: support for NMDA hypofunction in schizophreniaState-dependent architecture of thalamic reticular subnetworks.Altered resting-state EEG source functional connectivity in schizophrenia: the effect of illness duration.A negative feedback loop controls NMDA receptor function in cortical interneurons via neuregulin 2/ErbB4 signalling.Oxidative stress and schizophrenia: recent breakthroughs from an old storyIn vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of conceptClinical and biochemical study of d-serine metabolism among schizophrenia patients.Mutations in the BLOC-1 subunits dysbindin and muted generate divergent and dosage-dependent phenotypes.Neuroimaging biomarkers for early drug development in schizophreniaElectrophysiological intermediate biomarkers for oxidative stress in schizophreniaNMDA receptor- and ERK-dependent histone methylation changes in the lateral amygdala bidirectionally regulate fear memory formation.Reduced CHRNA7 expression in C3H mice is associated with increases in hippocampal parvalbumin and glutamate decarboxylase-67 (GAD67) as well as altered levels of GABA(A) receptor subunits.Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals.Schizophrenia drug discovery and development in an evolving era: are new drug targets fulfilling expectations?Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia.Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders.
P2860
Q24202544-837951DD-F6C6-466E-A64A-0EC7B96A8018Q26741916-ECCA04FF-E1A3-4535-B1C4-88BD918E5C8AQ26769948-E88CDFEC-1AEC-4B73-8578-3BBE6180E0FFQ26796401-2E9058B3-FA9A-4053-ADE0-5E6CF4051450Q26830600-72E36928-9D06-4D9F-8FC6-CA09A68A937EQ26860217-E2A8BE3C-B05A-4A82-80E4-560F4F472078Q26999554-DE13D410-6469-42AA-90BA-DD2607A7872CQ27308949-7485B010-B46C-4AD6-AFD4-AEF9FAAD514EQ27319891-165399C8-376A-4B48-9847-70FC313363CBQ27338525-05626713-E7C2-4CAF-A706-A0BFF7292A3AQ27500448-10C8B0A2-C9C1-4698-94E6-CD59008F3A7DQ28067617-0CA4FDD4-2F92-4A19-96DB-BDE126BF0123Q28073684-EC4DFBA1-B9A4-4636-9C6E-CD25E4461056Q28087255-2149825B-3BFE-4117-9FC0-CC6B15BA7CD6Q30355619-62C96BF9-B8B4-4168-87BB-E96834452E45Q30359654-40EF805D-AC4E-4664-88D6-02557E74A7F4Q30384905-E444376F-E2A6-46E8-BCC7-7F27B351819BQ30388341-0A95D2C3-4EA0-4DE4-99F9-D18D94DB748EQ30403787-D7927CC2-1B0E-4C7B-80ED-E579803F6C89Q30405706-2AC7F22A-B0B3-4B2A-80B5-82D8EF090742Q30425712-274DE202-0320-4076-8F97-097D6415BDEFQ30435763-8EE4C7E0-3E34-4E10-B91C-35168D56DE46Q30436342-793B6A1E-56E1-4546-8260-5CE58DE21AB3Q30446951-05599866-94F4-4655-AF43-B377CE79C68AQ30454156-C2489583-2A46-4192-8BFC-EE515A93EC76Q30594812-DF921EC8-0858-48DE-9716-28A316934ECBQ30647676-028CB87F-4D0D-4896-B2F4-90CFF03D7E59Q30652639-A0DA6B82-FA31-4112-8A02-5EC3CF9F8766Q30774039-3F7E6815-D1BE-4705-88C3-FB9D40CE2D37Q30976220-649C0152-1BAE-4B5D-9731-931FC9A7F13DQ33565101-C967CE0A-5D24-4DDE-99BB-337E1D85F8F7Q33619538-7B7FE095-BFDF-4B03-A7AE-96ADF4C59A43Q33632516-ED30733C-E57E-4AE6-AD09-48269DA711E3Q33647885-25488B90-F517-43B2-BB6C-97B3801B90EAQ33770536-AE145946-F2D6-4A1B-9514-A020703E96CDQ34004330-BF099939-2650-4703-A4FC-FBF772A1F4D0Q34162964-F92BB80C-D1D1-4164-BF97-E32638A12B8EQ34458090-2A13BDA9-1CB9-4A75-838D-051989A9DECCQ34534903-90724348-36B3-45A5-A021-6B11E1170752Q34557613-D0689F3C-3B0E-4E9E-9621-19E8DEF2CDD0
P2860
NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
NMDA receptor hypofunction, pa ...... oscillations in schizophrenia.
@ast
NMDA receptor hypofunction, pa ...... oscillations in schizophrenia.
@en
type
label
NMDA receptor hypofunction, pa ...... oscillations in schizophrenia.
@ast
NMDA receptor hypofunction, pa ...... oscillations in schizophrenia.
@en
prefLabel
NMDA receptor hypofunction, pa ...... oscillations in schizophrenia.
@ast
NMDA receptor hypofunction, pa ...... oscillations in schizophrenia.
@en
P2860
P356
P1476
NMDA receptor hypofunction, pa ...... oscillations in schizophrenia.
@en
P2860
P304
P356
10.1093/SCHBUL/SBS010
P407
P577
2012-02-21T00:00:00Z